Leukaemic cells resistant to conventional chemotherapy show a disturbed response to oxidant stress, which provide an advantage to subclones that overexpress ALDH1A1 and explain the association between increased ALDH1A RNA expression and poor prognosis in AML. This evidence concerns the gene ALDH1A1 and acute myeloid leukemia.